Mission ID Programs -- Peru - SOTA

Download Report

Transcript Mission ID Programs -- Peru - SOTA

Addressing the Threats of
Emerging and Re-emerging
Infectious Diseases
Proyecto VIGIA
Activity 527- 0391
1
VIGIA: Basic Data

Funding Source:
Development Assistance
(Child Survival and
Disease Program).

Estimated Live of
Activity:
September 1997 September 2004

USAID funding:
$ 18.0 million

GoP funding:
$ 6.0 million
2
VIGIA Project
Colombia
Brazil
A
Area:
496,222 sq mi.
Population:
25´662,000
Capital:
Lima
Highest point:
Huascaran 22,205 ft.
Ecosystem or life zones:
84 (101)
Bolivia
Chile
3
VIGIA Project
General Objective:
 Improve health of high risk populations.
Purpose:
 Strengthen national and local capacity to
identify, control and prevent emerging and reemerging infectious diseases effectively.
4
VIGIA Project
Components:
1. Surveillance
2. Applied research
3. Prevention and control
4. Laboratory
5
VIGIA: Expected Results
1) People's health status will improve.
2) The health services will enact more
effective protective measures.
3) A strengthened surveillance and research
system will be in place.
4) Epidemics and outbreaks will be avoided.
6
VIGIA: Implementing Partner &
Relationships I
MoH
Minister
Vice-Minister
Project Director
(MoH)
1. General Directorate for
Health Care
Technical
assistance
organizations
2. General Directorate for
Environmental Health
3. General Epidemiology
Office
MoH
Regions/ DISAS
Hospitals
Others
4. General Directorate for
Medicines, Supplies and
Drugs
5. National Institute of Health
USAID
NIH
Administrative
General Office
7
VIGIA Relationships II
Hired
consultants
Technical
assistance
Administrative and
support personnel
(6)
Project
Director
Project
Sub-Director
Macro-Regional
Coordinators
(3 - 4)
• Project Coordinator
• Project Officer
• Administrative
assistant
At OHPN / USAID
USAID
Support
Offices
Regional
Coordinators
(3)
8
Main Project Activities to date
Technical and financial support in the
organization of technical meetings on
subjects such as:

Yellow Fever

Hantavirus

Resistance to antimalarials

Roll Back Malaria in the Americas

Hospital Infections

The implementation of a Public Health
Reference Laboratories Network in the
Amazon Basin

National antimalarial drugs policy
9
Main Project Activities to date
Component 1. Surveillance
•
The preparation of an entomological map for Peru.
•
The strengthening of the National Epidemiology network
with computer equipment.
•
The evaluation of the National Epidemiological Surveillance
Network and the design of an Information system for this
network.
•
The strengthening of epidemiological surveillance of acute
respiratory infections (H. influenzae and S. Pneumoniae).
•
The implementation, in a group of pilot hospitals, of hospital
infection surveillance and control committees.
10
Main Project Activities to date
Component 1. Surveillance (cont.)
•
The study of Hospital infection prevalence in several hospitals.
•
The design and operation of a specialized virtual library on
emergent and re-emergent infectious diseases.
•
The Surveillance of icteric and febrile syndromes.
•
Strengthening infrastructure of HIV/AIDS surveillance.
•
Sentinel surveillance HIV/AIDS and Plague.
•
Design and implementation of a vectors and reservoirs
surveillance system.
11
Main Project Activities to date
Component 2. Applied Research
•
The evaluation of the efficacy of antimalarial drugs
in non-complicated falciparum malaria.
•
The evaluation of a rapid test for malaria diagnosis
as used by health promoters.
•
The design of a new Field Epidemiology Training
Program, and its implementation.
•
The assessment of the economic impact of malaria
in Peru.
•
The identification of priorities for research in Public
Health.
12
Main Project Activities to date
Component 2. Applied Research
•
The preparation of guidelines concerning ethics in research
with human subjects.
•
An analytical review of etnographic and other qualitative
studies carried out in Peru concerning emergent and reemergent infectious diseases.
•
The study of social and anthropological characteristics of
populations at risk of suffering Yellow Fever.
•
Systematization of malaria and dengue control activities in
three Health Regions.
•
The evaluation of alternative immunization strategies for
Yellow Fever control.
13
Main Project Activities to date
Component 2. Applied Research
• The study of economic impact of tuberculosis in Peru.
• The economic evaluation of alternative strategies
in TB control.
• A socio-anthropological study of factors associated
with severity and lethality of TB in selected areas.
• Systematization of Peruvian experience in malaria
control.
• Funding of small research projects carried out
by MoH health professionals.
14
Main Project Activities to date
Component 2. Applied Research
•
The detection of insecticide resistance among
malaria vectors.
•
A socio-anthropological study concerning febrile
diseases presenting with jaundice and/or bleeding
in the Cusco and Ayacucho Regions.
•
A feasibility study of the introduction of intermittent
flooding in rice cultivation as an instrument for
malaria control.
15
Peru: Cases Malaria
1939 - 2001
Perú: Casos de malaria regis trados anua lmente
(Fuente: OGE/MINSA)
250000
200000
150000
100000
50000
9
5
19
9
19
9
1
7
19
9
19
8
3
9
19
8
19
7
5
1
19
7
7
19
7
3
19
6
9
19
6
19
5
5
1
19
5
19
5
7
3
19
4
19
4
19
3
9
0
16
Cases of Malaria vs cultivate hct. of rice
Ambito de la Disa Piura I: Correlación entre casos de malaria
registrados y hectáreas de arroz cultivadas, 1994-1999*
50,000
40,000
Casos de Malaria
Has de arroz
(r = 0,95)
30,000
20,000
10,000
0
1994
1995
1996
1997
1998
1999*
*1999 casos de Malaria hasta noviembre. Hectareas sembradas en Valles Medio y B ajo Piura y Alto Piura.
Fuentes: DIS A Piura I, MINAG.
17
Main Project Activities to date
Laboratory Resources
•
Implementation of the final studies for the construction
of two high biosafety level laboratories.
•
Strengthening of the Public Health reference
Laboratories Network with computer and laboratory
equipment.
•
Strengthening, at the local level, of the capacity to
diagnose Plague in three regional laboratories
(Cajamarca, Jaen and Lambayeque).
18